COVID 19 in Antimicrobial and Antibacterial Agents

COVID-19  caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally Bacterial co-infections are correlated with unfavorable outcomes in respiratory viral infections. Despite, microbiological and antibiotic data related to COVID-19 are skimpy, competent use of antibiotics in line with antibiotic stewardship (ABS) principles is guaranteed during the pandemic. Bacterial and fungal co-infections are subtle in COVID-19 patients and are mainly ubiquitous in critically ill patients. In addition, studies are needed to estimate the impact of antimicrobial therapy on therapeutic outcomes in COVID-19 patients to prevent antimicrobial overuse. A novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was consequently identified as the causative pathogen. Ordinarily, respiratory viral infections are a risk factor for bacterial co-infections, which then increase disease austerity and mortality. It has been established that sepsis and ventilator-associated pneumonia are frequently observed complications in COVID-19 patients.

    Related Conference of COVID 19 in Antimicrobial and Antibacterial Agents

    May 25-26, 2022

    International Conference on Vaccine & Vaccine Research

    Auckland, Newzealand
    June 23-24, 2022

    International Congress on Vaccines and Virology

    Zurich, Switzerland
    June 23-24, 2022

    Global Summit on Vaccines & Emerging Diseases

    Zurich, Switzerland
    June 23-24, 2022

    35th World Congress on Vaccines and Immunization

    Bangkok, Thailand
    June 27-28, 2022

    Global Summit on Hepatitis Vaccine

    Zurich, Switzerland
    September 05-06, 2022

    42nd Global Summit and Expo on Vaccines & Immunology

    Paris, France
    October 05-06, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland
    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany

    COVID 19 in Antimicrobial and Antibacterial Agents Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in